Updated Jul 16, 2026 · Last SEC filing 2026-06-12
Cryoport, Inc. (CYRX) has filed 7 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-12. 2 Form 8-K material event filings were reported by CYRX in the last 90 days. 4 Form 144 notices of proposed sale were filed for CYRX stock. InsiderAlpha tracks every CYRX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001124524 |
|---|
| Form 4 filings (90d) | 7 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-06-12 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| ZECCHINI EDWARD J | Chief Digital and Tech Officer | S — Open-market sale | 33.6K | $14.47 | $486K | SEC | |
| ZECCHINI EDWARD J | Chief Digital and Tech Officer | M — Option exercise | 33.6K | $4.80 | $161K | SEC | |
| ZECCHINI EDWARD J | Chief Digital and Tech Officer | S — Open-market sale | 1.4K | $15.23 | $21K | SEC | |
| ZECCHINI EDWARD J | Chief Digital and Tech Officer | M — Option exercise | 1.4K | $4.80 | $7K | SEC | |
| Mandalam Ramkumar | Director | S — Open-market sale | 23.2K | $15.44 | $358K | SEC | |
| HANCOCK DANIEL M | Director | A — Grant or award | 10.3K | $0.00 | — | SEC | |
| Hariri Robert J | Director | A — Grant or award | 10.3K | $0.00 | — | SEC | |
| BADDOUR LINDA | Director | A — Grant or award | 10.3K | $0.00 | — | SEC | |
| Mandalam Ramkumar | Director | A — Grant or award | 10.3K | $0.00 | — | SEC | |
| STEFANOVICH ROBERT | Chief Financial Officer | S — Open-market sale | 169.4K | $16.27 | $2.76M | SEC | |
| SHELTON JERRELL | President, CEO | M — Option exercise | 104.0K | $1.87 | $194K | SEC | |
| SHELTON JERRELL | President, CEO | M — Option exercise | 50.0K | $1.87 | $94K | SEC | |
| SHELTON JERRELL | President, CEO | S — Open-market sale | 2.9K | $8.18 | $24K | SEC | |
| STEFANOVICH ROBERT | Chief Financial Officer | S — Open-market sale | 1.1K | $8.18 | $9K | SEC | |
| Sawicki Mark W | Chief Scientific Officer | S — Open-market sale | 1.3K | $8.18 | $11K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Cryoport, Inc. (CYRX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| ZECCHINI EDWARD J | 6 | $676K |
| Mandalam Ramkumar | 3 | $358K |
| BADDOUR LINDA | 2 | — |
| HANCOCK DANIEL M | 2 | — |
| Hariri Robert J | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CYRX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live CYRX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.